Posts in category

Business


Wholesaler to recover close to one third of the debt it is owed by the collapsed Infinity Pharmacy Group  A preliminary estimated outcome analysis by the administrators of the Infinity Pharmacy Group reveals Paragon …

One leading pharmacist outlines why the 2026 federal Budget was such a disappointment, as a new position statement highlights the importance of MBS access “At a broad level, the Budget …

Pharmacy is one of the few sectors to see increased spending, as household budgets tighten, the Commonwealth Bank of Australia reveals  Data from the CommBank Household Spending Insights report for …

Demand for pharmacies is at an historic high, but buyer preferences are changing, insights indicate The pharmacy market is experiencing the strongest demand since the Covid pandemic, but buyers are …

Despite headline figures, a peak body says PBS expenditure will slow as a share of GDP – and it could have implications for patients Future investment in the pharmaceutical benefits …

A glance at some of the business measures in the 2026/27 Federal Budget Here are some of the key business-related measures outlined by the government in the 2026 Federal Budget, …

Prospective buyers to break up Infinity Pharmacy Group, as the administrator agrees to exclusivity agreements   Negotiations for the sales of all 91 Infinity stores are entering the next phase, with preferred bidders for individual …

PharmX reports “significant strategic and commercial progress” in March 2026 quarter  Pharmacy ordering platform, PharmX, is forecasting its annualised gross transaction value (GTV) will grow to more than $100 million within the next …

Employee-owned pharmacy group signs deal to bring the Chemist Warehouse brand to London  Sigma Healthcare is set to license the Chemist Warehouse brand and intellectual property to a British pharmacy group, …

Australia’s pharmacy wholesale market is entering a “rebalancing” period following Chemist Warehouse’s merger with Sigma Healthcare, a rival firm says  Heightened competition in the pharmacy wholesale market is likely to stabilise, as …

Glucagon-like peptide-1 medications are already delivering significant growth for wholesalers, but the best is yet to come, Symbion’s chief executive says  Uptake of glucagon-like peptide-1 (GLP-1) products in Australia is on track for significant …

GLP-1s have provided a financial boost to pharmacies, but patients ineligible for subsidies say the cost of the medicines is often prohibitive. Kate Cowling reports on how the market is …